RUTGERS INNOVATIONS

Rutgers Office for Research proudly presents Rutgers Innovations, a bulletin that provides updates on Rutgers technologies and highlights collaborative and partnership opportunities for intellectual property-based assets.

Scan Ease: Temporary Bone-Supported Intraoral Scan Alignment Tool

Rutgers researchers have developed a fiducial marker that can be inserted into the bone without any surgical incision through the mucosa, aiding in aligning preoperative to postoperative intraoral scans as well as intraoral scans to Cone Beam Computed Tomography for cases involving partially dentate or completely edentulous patients.

New Drugs for the Prevention of Kidney Stones

Rutgers researchers have identified novel oxamates as potent inhibitors of calcium oxalate crystallization. These compounds, designed and synthesized in-house, were discovered using a crystallization inhibition assay developed at Rutgers.

Ion‐exchangeable Transparent and Opaque Glass‐ceramics

Rutgers researchers have created a glass-ceramic material, based on the nepheline and spinel system. Nepheline provides a strong glass‐forming ability, and it can be chemically strengthened. The presence of the spinel phase increases the hardness and fracture toughness of the glass‐ceramic.

Lightweight Macroscopic Crowd Identification

Rutgers researchers have created a novel, fast, and lightweight approach that makes conscious use of the onboard resources available in an Unmanned Aerial Vehicle (UAV) for the detection and identification of dominant crowd motion patterns in real time, taking only a few milliseconds to run on small, embedded modules.

piRNA Biogenesis in Insect Pests

Rutgers researchers have developed a potential permanent solution to persistent pest control issues by developing a system for genetic modification which could reduce the transmission of vector borne diseases (like malaria) from their insect vectors, or to establish expression of a desirable trait such as Bacillus thuringiensis susceptibility in crop pests.

Startups

Startups incorporated from technologies developed at Rutgers University

Zena Therapeutics

Rutgers startup Zena Therapeutics is a drug discovery company that is designing new medications for mental health and addiction by improving safety profiles. Zena is currently focused on acute anxiolytic compounds that do not increase the risk of overdose if taken concomitantly with other central nervous system depressing substances such as opioids and alcohol.

Derisked Through Commercial Grants

Available technologies that received Rutgers Bridge Funding awards

Surgical Artificial Intelligence Ureteral Injury Prevention System

Rutgers researchers have developed an AI‐based technology to assist in preventing iatrogenic ureter injury. The new system will continuously monitor the location of the surgical instruments and will alert or if necessary halt movement once the critical safety distance from the ureter is reached.

Learn more about Rutgers Innovations

Contact Eusebio Pires, PhD, MBA at marketingbd@research.rutgers.edu

for business development and partnering opportunities.

Rutgers Technology Transfer is part of the Office for Research.